Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no flat per-compound pricing increases, making weekly self-administration a consistent, predictable investment
FDA approval is projected for late 2026 to early 2027, with Health Canada approval likely to follow
Regardless, researchers and manufacturers of Ozempic and Wegovy do say that these drugs are most successful when they're incorporated into a treatment plan in conjunction with healthier diet and lifestyle changes
Heres what we know about when generics might hit the market for the most in-demand GLP-1 drugs: Ozempic / Wegovy (semaglutide) Patents begin expiring in March 2026, but Novo Nordisk holds secondary patents that could extend exclusivity into 2033
US$ 23.37
US$ 25.63
US$ 23.86
US$ 21.58
US$ 22.94
US$ 28.21
US$ 21.55
